Reykjavik, Iceland - (November 9, 2009) - Jon Sigurdsson, president and CEO of Össur Hf., celebrated the company's tenth year of trading publically on NASDAQ OMX by ringing the NASDAQ stock market Closing Bell in New York City today.

The listing has served the Company well. Since the initial listing, sales have grown more than twenty times and Ossur has transformed from a Prosthetics Company into a global player in the non-invasive orthopaedics.

Össur is the proud Icelandic developer and manufacturer of non-invasive orthopaedics that has survived a most challenging year. A global leader in its category, the company has weathered the storm thanks to its clear focus on improving people's mobility through the delivery of innovative technologies within the fields of bracing and supports, prosthetic limbs and compression therapies.

"Our outlook has always been on a global scale, and this thinking has served us well," said Mr. Sigurdsson, a World Economic Forum TechPioneer alumnus. "It is especially fitting that we should celebrate this honor in the United States, where we have extensive operations and have enjoyed an increase in sales in the 3rd Quarter of this year," he added. Össur is best known as the purveyor of the Cheetah Flex-Foot, the prosthetic device of choice for elite amputee athletes like Oscar Pistorius who recently challenged the IAAF for the right to compete against able-bodied athletes in the Olympics, and won. It is also the first company in the world to bring bionic prosthetic feet and knees to market, including the RHEO KNEE, the POWER KNEE, and the PROPRIO FOOT. In the past five years, Össur acquired a number of orthopaedic companies, and is renowned for its proven solution for Knee Osteoarthritis, the Unloader One brace. 

 

Össur (Nasdaq OMX: OSSR/ OSSR DKK) is a global leader in non-invasive orthopaedics that help people live a life without limitations. Its business is focused on improving people's mobility through the delivery of innovative technologies within the fields of braces, supports, prosthetic limbs and compression therapies. A recognized "Technology Pioneer," Ossur invests significantly in research and product development; its award-winning designs ensuring a consistently strong position in the market. Successful patient and clinical outcomes are further empowered via Ossur's educational programs and business solutions. Headquartered in Iceland, Ossur has major operations in the Americas, Europe and Asia, with additional distributors worldwide.  Website:  www.ossur.com

Ossur Investor Relations
Sigurborg Arnarsdóttir
Tel.: +354 515 1339
sarnarsdottir@ossur.comt